Chenlu Yang

Cancer Center And State Key Laboratory Of Biotherapy
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Small-molecule inhibition of YTHDC1 as a strategy against acute myeloid leukemia in mouse models.

Small-molecule inhibition of YTHDC1 as a strategy against acute myeloid leukemia in mouse models.

Journal: Science translational medicine

Published: February 04, 2026

Optimizing treatment for Waldenström macroglobulinemia-associated acquired von Willebrand syndrome: a case report and literature review.

Optimizing treatment for Waldenström macroglobulinemia-associated acquired von Willebrand syndrome: a case report and literature review.

Journal: Frontiers in oncology

Published: December 12, 2025

Mecapegfilgrastim for Prophylaxis of Immunochemotherapy-Induced Neutropenia in Patients With Diffuse Large B-Cell Lymphoma: A Multicenter Pilot Trial.

Mecapegfilgrastim for Prophylaxis of Immunochemotherapy-Induced Neutropenia in Patients With Diffuse Large B-Cell Lymphoma: A Multicenter Pilot Trial.

Journal: Cancer medicine

Published: September 17, 2025

Born with two faces: sequential DLBCL, NOS and TFHL-AI with TET2 mutation - a case report.

Born with two faces: sequential DLBCL, NOS and TFHL-AI with TET2 mutation - a case report.

Journal: Frontiers in immunology

Published: September 04, 2025

Unmasking the Esophageal Submucosal Enigma.

Unmasking the Esophageal Submucosal Enigma.

Journal: Digestive diseases and sciences

Published: July 10, 2025

Venetoclax plus decitabine, cytarabine, aclarubicin, and G-CSF in adults with newly diagnosed acute myeloid leukemia: A multicenter, retrospective study.

Venetoclax plus decitabine, cytarabine, aclarubicin, and G-CSF in adults with newly diagnosed acute myeloid leukemia: A multicenter, retrospective study.

Journal: International journal of cancer

Published: June 19, 2025

Myelodysplastic Neoplasms (MDS): Pathogenesis and Therapeutic Prospects.

Myelodysplastic Neoplasms (MDS): Pathogenesis and Therapeutic Prospects.

Journal: Biomolecules

Published: March 30, 2025

The clinical characteristics and implications of acute kidney injury during induction therapy for acute promyelocytic leukemia.

The clinical characteristics and implications of acute kidney injury during induction therapy for acute promyelocytic leukemia.

Journal: Frontiers in pharmacology

Published: December 05, 2024

Standard dose anthracycline plus all-trans retinoic acid and arsenic trioxide as induction chemotherapy significantly reduces early death and relapse for high-risk acute promyelocytic leukemia: a single-center real-world analysis.

Standard dose anthracycline plus all-trans retinoic acid and arsenic trioxide as induction chemotherapy significantly reduces early death and relapse for high-risk acute promyelocytic leukemia: a single-center real-world analysis.

Journal: Therapeutic advances in hematology

Published: July 14, 2024

Zanubrutinib-induced aseptic meningitis: a case report and literature review.

Zanubrutinib-induced aseptic meningitis: a case report and literature review.

Journal: Frontiers in pharmacology

Published: June 19, 2023

Gastrointestinal Behçet Disease Secondary to Myelodysplastic Syndrome.

Gastrointestinal Behçet Disease Secondary to Myelodysplastic Syndrome.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: April 24, 2023

Arginine metabolism key enzymes affect the prognosis of myelodysplastic syndrome by interfering with macrophage polarization.

Arginine metabolism key enzymes affect the prognosis of myelodysplastic syndrome by interfering with macrophage polarization.

Journal: Cancer medicine

Published: February 18, 2023

Showing 1-12 of 15

Last Updated: 09/26/2026